COM:ORCHARD-TX
Orchard Therapeutics
- Stock
Last Close
16.65
23/01 21:00
Market Cap
380.11M
Beta: -
Volume Today
372.35K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
asset turnover | 0.01 - | 0.01 10.97% | 0.01 46.76% | 0.00 83.78% | 0.03 2,030.24% | |||
cash conversion cycle | -13.44K - | -3.06K 77.26% | -911.51 70.17% | 11.43K 1,353.76% | -134.99 101.18% | |||
cash per share | 3.46 - | 89.00 2,469.52% | 148.87 67.27% | 34.86 76.59% | 19.30 44.62% | 17.76 8.01% | 11.21 36.85% | |
company equity multiplier | -0.26 - | 1.13 534.42% | 1.18 4.41% | 1.33 13.51% | 1.57 17.98% | 1.54 2.47% | 2.23 45.07% | |
days of inventory outstanding | 283.23 - | 3.26K 1,049.59% | 510.07 84.33% | |||||
days of payables outstanding | 15.68K - | 5.43K 65.34% | 3.76K 30.84% | 16.16K 330.13% | 1.40K 91.35% | |||
days of sales outstanding | 2.24K - | 2.38K 6.20% | 2.56K 7.76% | 24.34K 849.49% | 752.83 96.91% | |||
dividend yield | ||||||||
ebit per revenue | -113.21 - | -68.79 39.24% | -60.49 12.06% | -75.39 24.63% | -4.52 94.00% | |||
ebt per ebit | 0.99 - | 1.03 3.81% | 0.98 5.24% | 0.96 1.87% | 0.97 1.52% | 0.99 2.26% | 0.29 71.32% | |
effective tax rate | -0.00 - | -0.00 27.29% | -0.00 216.49% | 0.01 419.95% | 0.00 64.60% | -0.00 172.09% | 0.13 3,730.44% | |
enterprise value multiple | -7.18 - | -1.35 81.23% | -0.08 94.00% | -7.98 9,757.41% | -2.92 63.44% | -4.70 61.35% | -4.59 2.38% | |
fixed asset turnover | 0.38 - | 0.09 75.46% | 0.08 19.38% | 0.02 77.86% | 0.23 1,260.80% | |||
free cash flow per share | -14.62 - | -33.72 130.73% | -45.02 33.51% | -18.29 59.39% | -13.97 23.59% | -10.35 25.90% | -6.43 37.84% | |
gross profit margin | 0.80 - | 0.68 14.69% | 0.67 1.46% | 0.53 20.55% | 0.65 22.49% | |||
interest coverage | -112.40 - | -67.43 40.01% | -53.32 20.93% | -33.86 36.49% | ||||
inventory turnover | 1.29 - | 0.11 91.30% | 0.72 538.33% | |||||
long term debt to capitalization | 0.12 - | 0.20 68.81% | 0.20 1.30% | 0.30 52.94% | ||||
net income per ebt | 1.00 - | 1.00 0.03% | 1.00 0.29% | 0.99 1.77% | 1.00 0.89% | 1.00 0.83% | 0.87 12.83% | |
net profit margin | -111.03 - | -65.03 41.43% | -58.57 9.94% | -75.26 28.50% | -1.13 98.50% | |||
operating cash flow per share | -14.43 - | -32.18 123.03% | -43.24 34.36% | -17.82 58.79% | -12.70 28.73% | -10.09 20.53% | -5.93 41.27% | |
operating cycle | 2.24K - | 2.38K 6.20% | 2.85K 19.66% | 27.59K 869.40% | 1.26K 95.42% | |||
operating profit margin | -113.21 - | -68.79 39.24% | -60.49 12.06% | -75.39 24.63% | -4.52 94.00% | |||
payables turnover | 0.02 - | 0.07 188.51% | 0.10 44.60% | 0.02 76.75% | 0.26 1,056.27% | |||
pretax profit margin | -110.56 - | -65.92 40.38% | -58.85 10.73% | -75.00 27.44% | -1.29 98.28% | |||
price fair value | -8.55 - | 1.64 119.12% | 1.14 30.32% | 4.29 275.95% | 2.41 43.81% | 0.78 67.63% | 0.48 38.06% | |
receivables turnover | 0.16 - | 0.15 5.84% | 0.14 7.20% | 0.01 89.47% | 0.48 3,132.54% | |||
return on assets | -4.46 - | -0.41 90.83% | -0.63 54.15% | -0.41 35.00% | -0.54 32.17% | -0.11 79.16% | -0.04 68.06% | |
return on capital employed | -41.03 - | -0.45 98.92% | -0.74 66.01% | -0.50 31.86% | -0.68 35.96% | -0.13 80.97% | -0.20 53.20% | |
return on equity | 1.15 - | -0.46 139.82% | -0.74 60.95% | -0.55 26.22% | -0.85 55.94% | -0.17 79.67% | -0.08 53.66% | |
total debt to capitalization | 0.13 - | 0.25 84.80% | 0.22 10.20% | 0.37 68.28% |
All numbers in USD (except ratios and percentages)